Biopharma CreditBOPCF
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$0.89avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Biopharma Credit PLC (BOPCF) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Aubrey Capital Management Ltd ($1.4M).
- Company
- Biopharma Credit PLC
- CUSIP
- G12808104
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 166,786 shares bought, net +166,786 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Aubrey Capital Management Ltd | 0.52% | Add +12.2% | 1,538,038 | $1.4M |
"% of holder's portfolio" is BOPCF's weight in each manager's 13F, not the share of Biopharma Credit PLC the manager owns.